| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Department of Medicine, Genetics, Cancer Center, and Institute for Human Gene Therapy, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
The c-Myc oncoprotein is a transcription factor involved in cellular transformation. We previously found (M. V. Blagosklonny, et al., Cancer Res., 57: 320–325, 1997) that exposure of human SkBr3 breast cancer and LNCaP prostate cancer cells to 12-O-tetradecanoylphorbol-13-acetate (TPA) led to a growth arrest associated with the up-regulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 and the inhibition of c-Myc expression. We show here that exogenous c-Myc inhibits p21 expression in SkBr3 and LNCaP cells induced to enter into S-phase. p27 expression was not increased from basal levels in TPA-treated growth-arrested cells. A time course after infection of TPA-arrested cells using a c-Myc-expressing adenovirus revealed that the inhibition of p21 expression preceded entry into S-phase. In contrast, after infection by E2F-1-expressing adenovirus, p21 expression was reduced after the cells entered S-phase. Overexpression of c-Myc reduced the levels of endogenous p21 mRNA, and transfection of c-Myc repressed p21-promoter luciferase-reporter gene expression. The results suggest that the down-regulation of p21 expression may contribute to c-Myc-dependent entry into S-phase, possibly in situations in which growth arrest is associated with increased p21 expression.
This article has been cited by other articles:
 |
|
 |
|
  R. Liu, L. Wang, G. Chen, H. Katoh, C. Chen, Y. Liu, and P. Zheng FOXP3 Up-regulates p21 Expression by Site-Specific Inhibition of Histone Deacetylase 2/Histone Deacetylase 4 Association to the Locus Cancer Res., March 15, 2009; 69(6): 2252 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Hwang-Verslues and F. M. Sladek Nuclear Receptor Hepatocyte Nuclear Factor 4{alpha}1 Competes with Oncoprotein c-Myc for Control of the p21/WAF1 Promoter Mol. Endocrinol., January 1, 2008; 22(1): 78 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-M. Bae, H. Wang, G. Jiang, M. G. Chen, L. Lu, and L. Xiao Protein Kinase C{varepsilon} Is Overexpressed in Primary Human Non-Small Cell Lung Cancers and Functionally Required for Proliferation of Non-Small Cell Lung Cancer Cells in a p21/Cip1-Dependent Manner Cancer Res., July 1, 2007; 67(13): 6053 - 6063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Gong, J. Yue, X. Wu, X. Wang, J. Wen, L. Lu, X. Peng, B. Qiang, and J. Yuan NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element Nucleic Acids Res., December 4, 2006; 34(21): 6158 - 6169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dose, I. Khan, Z. Guo, D. Kovalovsky, A. Krueger, H. von Boehmer, K. Khazaie, and F. Gounari c-Myc mediates pre-TCR-induced proliferation but not developmental progression Blood, October 15, 2006; 108(8): 2669 - 2677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Kokkinakis, A. G. Brickner, J. M. Kirkwood, X. Liu, J. E. Goldwasser, A. Kastrama, C. Sander, D. Bocangel, and S. Chada Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress Mol. Cancer Res., August 1, 2006; 4(8): 575 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Nagl Jr., D. R. Zweitzig, B. Thimmapaya, G. R. Beck Jr., and E. Moran The c-myc Gene Is a Direct Target of Mammalian SWI/SNF-Related Complexes during Differentiation-Associated Cell Cycle Arrest Cancer Res., February 1, 2006; 66(3): 1289 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sakaguchi, H. Sonegawa, T. Nukui, Y. Sakaguchi, M. Miyazaki, M. Namba, and N.-h. Huh Bifurcated converging pathways for high Ca2+- and TGF{beta}-induced inhibition of growth of normal human keratinocytes PNAS, September 27, 2005; 102(39): 13921 - 13926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. L. Ho, W. Ma, D. Y. L. Mao, and S. Benchimol p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest Mol. Cell. Biol., September 1, 2005; 25(17): 7423 - 7431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Gartel and S. K. Radhakrishnan Lost in Transcription: p21 Repression, Mechanisms, and Consequences Cancer Res., May 15, 2005; 65(10): 3980 - 3985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mukherjee and S. E. Conrad c-Myc Suppresses p21WAF1/CIP1 Expression during Estrogen Signaling and Antiestrogen Resistance in Human Breast Cancer Cells J. Biol. Chem., May 6, 2005; 280(18): 17617 - 17625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liu, L. Li, J. N. Rao, T. Zou, H. M. Zhang, D. Boneva, M. S. Bernard, and J.-Y. Wang Polyamine-modulated expression of c-myc plays a critical role in stimulation of normal intestinal epithelial cell proliferation Am J Physiol Cell Physiol, January 1, 2005; 288(1): C89 - C99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Ricci, Z. Jin, M. Dews, D. Yu, A. Thomas-Tikhonenko, D. T. Dicker, and W. S. El-Deiry Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity Mol. Cell. Biol., October 1, 2004; 24(19): 8541 - 8555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Thomas-Tikhonenko, I. Viard-Leveugle, M. Dews, P. Wehrli, C. Sevignani, D. Yu, S. Ricci, W. el-Deiry, B. Aronow, G. Kaya, et al. Myc-Transformed Epithelial Cells Down-Regulate Clusterin, Which Inhibits Their Growth in Vitro and Carcinogenesis in Vivo Cancer Res., May 1, 2004; 64(9): 3126 - 3136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. McConnell, N. Chevallier, W. Berkofsky-Fessler, J. M. Giltnane, R. B. Malani, L. M. Staudt, and J. D. Licht Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression Mol. Cell. Biol., December 15, 2003; 23(24): 9375 - 9388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Baluchamy, H. N. Rajabi, R. Thimmapaya, A. Navaraj, and B. Thimmapaya Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity PNAS, August 5, 2003; 100(16): 9524 - 9529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yu, K. Matsusue, P. Kashireddy, W.-Q. Cao, V. Yeldandi, A. V. Yeldandi, M. S. Rao, F. J. Gonzalez, and J. K. Reddy Adipocyte-specific Gene Expression and Adipogenic Steatosis in the Mouse Liver Due to Peroxisome Proliferator-activated Receptor gamma 1 (PPARgamma 1) Overexpression J. Biol. Chem., January 3, 2003; 278(1): 498 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Weinberg and M. F. Denning P21WAF1 CONTROL OF EPITHELIAL CELL CYCLE AND CELL FATE Critical Reviews in Oral Biology & Medicine, November 1, 2002; 13(6): 453 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Misra, C. Qi, S. Yu, S. H. Shah, W.-Q. Cao, M. S. Rao, B. Thimmapaya, Y. Zhu, and J. K. Reddy Interaction of PIMT with Transcriptional Coactivators CBP, p300, and PBP Differential Role in Transcriptional Regulation J. Biol. Chem., May 24, 2002; 277(22): 20011 - 20019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Sheen and R. B. Dickson Overexpression of c-Myc Alters G1/S Arrest following Ionizing Radiation Mol. Cell. Biol., March 15, 2002; 22(6): 1819 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yu, W.-Q. Cao, P. Kashireddy, K. Meyer, Y. Jia, D. E. Hughes, Y. Tan, J. Feng, A. V. Yeldandi, M. S. Rao, et al. Human Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Supports the Induction of Peroxisome Proliferation in PPARalpha -deficient Mouse Liver J. Biol. Chem., November 2, 2001; 276(45): 42485 - 42491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U-J Gohring, A Bersch, M Becker, W Neuhaus, and T Schondorf p21waf correlates with DNA replication but not with prognosis in invasive breast cancer J. Clin. Pathol., November 1, 2001; 54(11): 866 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kolli, A. M. Buchmann, J. Williams, S. Weitzman, and B. Thimmapaya Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC PNAS, April 10, 2001; 98(8): 4646 - 4651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Gartel, X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A. L. Tyner Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 PNAS, March 22, 2001; (2001) 81074898. [Abstract] [Full Text]
|
|
|
|
|
|
K. O. Mitchell, M. S. Ricci, T. Miyashita, D. T. Dicker, Z. Jin, J. C. Reed, and W. S. El-Deiry Bax Is a Transcriptional Target and Mediator of c-Myc-induced Apoptosis Cancer Res., November 1, 2000; 60(22): 6318 - 6325. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-S. Park, L. Qiao, D. Gilfor, M. Y. Yang, P. B. Hylemon, C. Benz, G. Darlington, G. Firestone, P. B. Fisher, and P. Dent A Role for Both Ets and C/EBP Transcription Factors and mRNA Stabilization in the MAPK-dependent Increase in p21 Cip-1/WAF1/mda6 Protein Levels in Primary Hepatocytes Mol. Biol. Cell, September 1, 2000; 11(9): 2915 - 2932. [Abstract] [Full Text]
|
|
|
|
|
|
S. D. Conzen, K. Gottlob, E. S. Kandel, P. Khanduri, A. J. Wagner, M. O'Leary, and N. Hay Induction of Cell Cycle Progression and Acceleration of Apoptosis Are Two Separable Functions of c-Myc: Transrepression Correlates with Acceleration of Apoptosis Mol. Cell. Biol., August 15, 2000; 20(16): 6008 - 6018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Park, S. Boyer, K. Mitchell, D. Gilfor, M. Birrer, G. Darlington, W. El Deiry, G. L. Firestone, K. Munger, V. Band, et al. Expression of Human Papilloma Virus E7 Protein Causes Apoptosis and Inhibits DNA Synthesis in Primary Hepatocytes via Increased Expression of p21Cip-1/WAF1/MDA6 J. Biol. Chem., January 7, 2000; 275(1): 18 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, Y. Xu, D. Wonsey, L. A. Lee, and C. V. Dang Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc J. Biol. Chem., July 14, 2000; 275(29): 21797 - 21800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Gartel, X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A. L. Tyner Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 PNAS, April 10, 2001; 98(8): 4510 - 4515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Claassen and S. R. Hann A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest PNAS, August 15, 2000; 97(17): 9498 - 9503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, Q. Li, C. V. Dang, and L. A. Lee Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo PNAS, October 10, 2000; 97(21): 11198 - 11202. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
